UNO-A001

N/A

Report date: 2026/03/19 17:14:52

Base Information

Drug NameUNO-A001
Drug Alias NameUNO-A001
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody > Monoclonal antibody > Multispecific monoclonal antibody > Bispecific monoclonal antibodyBiologics > T cell engagers
Mechanisms of ActionAnti-CD38Anti-CD3
TargetsLymphocyte differentiation antigen CD38T cell surface glycoprotein CD3
Therapy Area/IndicationsMultiple Myeloma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesTavotek BiotherapeuticsUnogen Biotech Ltd
China Registration ClassN/A

Develop Information

Active CompaniesUnogen Biotech LtdTavotek Biotherapeutics
Inactive CompaniesN/A
Active IndicationsMultiple Myeloma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A